歸脾湯이 비소세포 폐암세포(NCI-H520) 이식 마우스에서 항암 및 면역 활성에 미치는 영향
Anticancer and Related Immunomodulatory Effects of Kwibi-tang on Non-small Cell Lung Carcinoma, NCI-H520, Xenograft Mice
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives : This study was to observe anticancer and related immunomodulatory effects of Kwibi-tang extracts (KBTe) on non-small cell lung carcinoma (squamous epithelial carcinoma), NCI-H520, xenograft Balb/c nu-nu nude mice. Methods : Three different dosages of KBTe, 50, 100 and 200 mg/kg were orally administered once a day for 42 days from 11 days after tumor cell inoculation. Six groups, each of 8 mice per group were used in the present study. Changes on the body weight, tumor volume and weight, lymphatic organ (spleen and popliteal lymph node), serum interferon (IFN)-γ levels, splenocytes NK cell activity and peritoneal macrophage activities, splenic tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 contents were observed with tumor mass and lymphatic organ histopathology to detect anticancer and immunomodulatory effects. The results were compared with a potent cytotoxic anticancer agent, 5-FU (5-Fluorouracil) 30 mg/kg, intraperitoneal treatment (3-day intervals for 42 days, the optimal effective treatment regimes already confirmed). Results & Conclusions : This study suggest that over 50 mg/kg of KBTe showed favorable anticancer effects on the NCI-H520 cell xenograft with immunomodulatory effects. Although relatively lower anticancer effects were observed in KBTe 200 mg/kg treated mice as compared with 5-FU 30 mg/kg treated mice, there are no meaningful favorable immunomodulatory effects were observed after 5-FU treatment in the present study.
Abstract
Objectives : This study was to observe anticancer and related immunomodulatory effects of Kwibi-tang extracts (KBTe) on non-small cell lung carcinoma (squamous epithelial carcinoma), NCI-H520, xenograft Balb/c nu-nu nude mice. Methods : Three different dosages of KBTe, 50, 100 and 200 mg/kg were orally administered once a day for 42 days from 11 days after tumor cell inoculation. Six groups, each of 8 mice per group were used in the present study. Changes on the body weight, tumor volume and weight, lymphatic organ (spleen and popliteal lymph node), serum interferon (IFN)-γ levels, splenocytes NK cell activity and peritoneal macrophage activities, splenic tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 contents were observed with tumor mass and lymphatic organ histopathology to detect anticancer and immunomodulatory effects. The results were compared with a potent cytotoxic anticancer agent, 5-FU (5-Fluorouracil) 30 mg/kg, intraperitoneal treatment (3-day intervals for 42 days, the optimal effective treatment regimes already confirmed). Results & Conclusions : This study suggest that over 50 mg/kg of KBTe showed favorable anticancer effects on the NCI-H520 cell xenograft with immunomodulatory effects. Although relatively lower anticancer effects were observed in KBTe 200 mg/kg treated mice as compared with 5-FU 30 mg/kg treated mice, there are no meaningful favorable immunomodulatory effects were observed after 5-FU treatment in the present study.
참고문헌 (51)
- "보건/사망원인시군구/사망원인(50항목) /성/사망자수, 사망률, 연령표준화 사망률(2005∼)"[URL]
- 김효진, "종양학", pp.304~ (2003), 일조각
- 김선영, "폐암 항암화학요법의 최신지견", 결핵 및 호흡기질환, 49(5), pp.533~545 (2000)
- 오인재, "비소세포 폐암 세포주에 대한 항암약제와 방사선 병합치료 방법의 개발", 박사, pp.2008
- Curran W, "Phase Ⅲ comparison of sequential vs comcurrent chemoradiation for patients (Pts) with unresected stage Ⅲ non-small cell lung cancer (NSCLC): Initial report of radiation teraphy oncology group (RTPG) 9410", Proc Am Sco Clin Oncol, 19, pp.484~ (2000)
- 박철규, "재발성 비소세포폐암에서 Pemetrexed 치료 효과와 Thymidylate Synthase 발현의 관계", Tuberculosis and Respiratory Diseases, 67(3), pp.191~198 (2009), 대한결핵및호흡기학회
- 조광현, "새로운 항암제에 의한 피부부작용", 대한피부과학회지, 48(4), pp.257~265 (2010), 대한피부과학회
- 유승후, "항암단을 투여한 재발성 편평상피폐암 환자에 대한 7년간의 추적조사", 대한한방내과학회지, 28(2), pp.387~392 (2007), 대한한방내과학회
- 박봉기, "수레바퀴 암치료를 시행한 폐암환자에 대한 후향적 코호트 분석", 대한한방내과학회지, (1), pp.45~56 (2008)
- 손지영, "호흡곤란을 주소로 한 폐암환자의 한방치료 증례보고", 대한한방내과학회지, 30(1), pp.233~240 (2009), 대한한방내과학회
- 김경순, "항암플러스 투여로 호전된 진행성 비소세포성 폐암 연속환자증례", 대한한방내과학회지, 30(4), pp.893~900 (2009), 대한한방내과학회
- 이승언, "폐암 세포주 H460에 대한 補中益氣湯의 세포괴사효과 및 기전연구", 대한한방내과학회지, 25(4), pp.274~288 (2004)
- 강윤경, "潤肺散에 의한 폐암세포 증식억제기전에 관한 연구", 동의생리병리학회지, 16(4), pp.20~755 (2002), 대한동의병리학회
- 김진영, "A539 및 NCI-H460 인체 폐암세포의 증식 및 apoptosis 유도에 미치는 가미삼기보폐탕의 영향", 대한한방내과학회지, 29(1), pp.130~148 (2008), 대한한방내과학회
- 嚴用和, "濟生方", pp.117~ (1980), 人民衛生出版社
- 김형철, "歸脾湯, 加味溫膽湯 및 歸脾溫膽湯의 抗 Stress 效能 比較硏究", 동의신경정신과학회지, 4, pp.99~119 (1993)
- 박선동, "歸脾湯 및 그 구성약물군이 항산화효과에 미치는 영향", 대한본초학회지, 16, pp.11~27 (2001)
- 임동욱, "加味歸碑湯 免疫調節作用에 미치는 影響", 대한한방부인과학회지, 12, pp.253~280 (1999)
- Isabelle Busta, "The Use of Gui-Pi-Tang in Small Animals with Immune-Mediated Blood Disorders", 한국임상수의학회지, 26(2), pp.181~184 (2009), 한국임상수의학회
- 김성호, "생쥐에서 歸脾湯 및 구성단미의 방사선 방호효과", 한국식품영양과학회지, 28, pp.698~704 (1999)
- Deveau AM, "Synthesis of diketopiperazine-based carboline homodimers and in vitro growth inhibition of human carcinomas", Bioorg Med Chem Lett, 18, pp.3522~3525 (2008)
- Shimizu Y, "Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant- negative mutant", Br J Cancer, 98, pp.915~922 (2008)
- Cooks T, "Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224", Int J Radiat Oncol Biol Phys, 74, pp.966~973 (2009)
- Institute of Laboratory Animal Resourcis, "Guide for the care and use of laboratory animals", pp.1~118 (1996), National Academic press
- Itoh H, "Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F Ⅲ-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma- bearing mice and its antitumor mechanism", Jpn J Pharmacol, 66, pp.265~271 (1994)
- Nishimura G, "An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells", Jpn J Cancer Res, 90(11), pp.1224~1230 (1999)
- Liu L, "Clinical and experimental study on regional administration of phosphorus 32 glass microspheres in treating hepatic carcinoma", World J Gastroenterol, 5, pp.492~505 (1999)
- Raffaghello L, "Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse", Cancer Lett, 197, pp.205~209 (2003)
- Clark BD, "Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays", J Appl Physiol, 71, pp.2412~2418 (1991)
- Hotchkiss RS, "Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin", Shock, 3, pp.337~342 (1995)
- 김명훈, "제 IV병기 비소세포폐암의 예후인자", Tuberculosis and Respiratory Diseases, 53(4), pp.379~388 (2002), 대한결핵및호흡기학회
- 김동희, "항암제 및 방사선 부작용에 대한 한방요법", 대한동의병리학회지, 9, pp.239~264 (1994)
- 方葯中, "실용중의내과학", pp.621~636 (1986), 상해과학기술 출판사
- 문구, "암동서의결합치료(Ⅰ)", pp.253~ (1999), 원광대학교출판국
- 국윤범, "方劑學", pp.290~292 (2008), 영림사
- Hanada M, "a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo", Cancer Sci, 98, pp.447~454 (2007)
- Okabe T, "Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification", Clin Cancer Res, 15, pp.907~913 (2009)
- Natsume T, "Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs", Anticancer Res, 26, pp.1145~1151 (2006)
- Foster PA, "Steroid metabolism in breast cancer", Minerva Endocrinol, 33, pp.27~37 (2008)
- Kim YC, "National survey of lung cancer in Korea", J Lung Cancer, 6, pp.67~73 (2007)
- Kondo H, "In vitro and in vivo effects of cisplatin and etoposide in combination on small cell lung cancer cell lines", Jpn J Cancer Res, 85(10), pp.1050~1056 (1994)
- Sogn JA, "Tumor immunology: the glass is half full", Immunity, 9, pp.757~763 (1998)
- Finke J, "Where have all the T cells gone? Mechanisms of immune evasion by tumors", Immunol Today, 20, pp.158~160 (1999)
- Pawelec G, "Escape mechanisms in tumor immunity: a year 2000 update", Crit Rev Oncog, 11(2), pp.97~133 (2000)
- Ha ES, "Anti-metastatic activity of glycoprotein fractionated from Acanthpanax senticosus, involvement of NK-cell and macrophage activation", Arch Pharm Res, 27, pp.217~224 (2004)
- 유경미, "In vitro 상에서 유자(Citrus junos SIEB ex TANAKA) 용매 추출물의 암세포 억제효과 및 항산화성", 한국식품과학회지, 36(2), pp.339~344 (2004), 한국식품과학회
- Sharkey FE, "Considerations in the use of nude mice for cancer research", Cancer Metastasis Rev, 3, pp.341~360 (1984)
- Kennedy JD, "Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age", J Immunol, 148, pp.1620~1629 (1992)
- Cheng WH, "Effect of dietary selenium and cancer cell xenograft on peripheral T and B lymphocytes in adult nude mice", Biol Trace Elem Res, 146(2), pp.230~235 (2012)
- Ferguson T, "Prevention and delay of spontaneous mammary and pituitary tumors by long- and short-term ingestion of 5-fluorouracil in Wistar -Furth rats", Oncology, 37, pp.353~356 (1980)
- Habs M, "Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5-fluorouracil", Int J Cancer, 28, pp.91~96 (1981)